BUY Opko Health, Inc. OPK – last $1.79. Add to position. Originally suggested at $2.36. 10.05.09, 2:17 pm EDT. OPK i9s a specialty healthcare company, engages in the discovery, development, and commercialization of proprietary pharmaceuticals, drug delivery technologies, diagnostic systems, and instruments for the treatment, diagnosis, and management of ophthalmic disorders. OPK announced Friday that [...]
BUY Golden Star Resources Ltd., (GSS) – last $3.80. GSS a gold mining and exploration company, through its subsidiaries, engages in the exploration and production of gold. It holds interests in various gold exploration projects in Ghana and elsewhere in West Africa, including Sierra Leone, Burkina Faso, Niger, and Côte d?Ivoire, as well as [...]
BUY CALL OPTIONS IN IQAAF.X – last $1.75. $30.00 strike, Jan 10, 2010. Underlying stock —- Illumina, Inc. (ILMN) – last $28.60. IMLN engages in the development, manufacture, and marketing of integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include Genome Analyzer II, an instrument for high-throughput sequencing using [...]
BUY Clarient, Inc. (CLRT) – last $2.66. CLRT provides oncology diagnostics services to community pathologists, biopharmaceutical companies, and researchers in the United States. It provides various cancer diagnostic and consultative services, including technical laboratory services and professional interpretation, such as reports and analyses through its Internet-based application, PATHSiTE; and commercial services to biopharmaceutical companies and [...]
